Zyla Life Sciences Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-05-20: Reporting owner Strobeck Mark; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-05-20: Reporting owner SMITH TODD N; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-05-20: Reporting owner SMITH TODD N; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2020-05-20: Reporting owner TIMMINS MEGAN C.; Form 4; Security Stock Option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-05-20 | Strobeck Mark Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −116,400 0 owned after | $1.50 exercise price | 2020-05-21 | |
| 2020-05-20 | SMITH TODD N Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −241,500 0 owned after | $1.50 exercise price | 2020-05-21 | |
| 2020-05-20 | SMITH TODD N Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −180,000 0 owned after | $2.37 exercise price | 2020-05-21 | |
| 2020-05-20 | TIMMINS MEGAN C. Officer (General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −84,700 0 owned after | $1.50 exercise price | 2020-05-21 | |
| 2020-03-04 | TIMMINS MEGAN C. Officer (General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,700 84,700 owned after | $1.50 exercise price | 2020-03-05 | |
| 2020-03-04 | Strobeck Mark Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +116,400 116,400 owned after | $1.50 exercise price | 2020-03-05 | |
| 2020-03-04 | SMITH TODD N Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +241,500 241,500 owned after | $1.50 exercise price | 2020-03-05 | |
| 2020-01-02 | SMITH TODD N Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +180,000 180,000 owned after | $2.37 exercise price | 2020-01-02 |